Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06100185 · ClinicalTrials.gov registry record · NA

Wearable Transcranial Electrical Stimulation (tES) for Insomnia

A NA study of Insomnia, sponsored by Uniformed Services University of the Health Sciences.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06100185 is a NA study of Insomnia that is actively recruiting participants, run by Uniformed Services University of the Health Sciences. The registered enrollment target is 100 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06100185, a NA study of Insomnia, is actively recruiting participants, sponsored by Uniformed Services University of the Health Sciences.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the ability of a translational device, Teledyne PeakSleep, to reduce sleep onset latency, reduce time awake after sleep onset and improve restfulness and the subjective benefits of sleep in a patient population with insomnia via transcranial direct current stimulation (tDCS) applied to frontal lobe circuits.

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE PeakSleep

Study Locations (1)

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-10-25
Est. Completion 2026-01
Phase NA

What the Registry Record Tells You About NCT06100185

The ClinicalTrials.gov registry entry for NCT06100185 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower). The listed sponsor is Uniformed Services University of the Health Sciences, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT06100185 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06100185 about?

NCT06100185 is a clinical study titled "Wearable Transcranial Electrical Stimulation (tES) for Insomnia". The purpose of this study is to investigate the ability of a translational device, Teledyne PeakSleep, to reduce sleep onset latency, reduce time awake after sleep onset and improve restfulness and the subjective benefits of sleep in a patient population with insomnia via transcranial direct current...

What is the current status of trial NCT06100185?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-25. Estimated completion is 2026-01.

What conditions does trial NCT06100185 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT06100185?

The interventions under investigation include: Sham (DEVICE), PeakSleep (DEVICE).

Who is sponsoring clinical trial NCT06100185?

This trial is sponsored by Uniformed Services University of the Health Sciences, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06100185 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.